ClinVar Miner

Submissions for variant NM_181486.4(TBX5):c.38C>A (p.Thr13Lys)

dbSNP: rs763125466
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000617189 SCV000737681 uncertain significance Cardiovascular phenotype 2022-11-17 criteria provided, single submitter clinical testing The p.T13K variant (also known as c.38C>A), located in coding exon 1 of the TBX5 gene, results from a C to A substitution at nucleotide position 38. The threonine at codon 13 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Fulgent Genetics, Fulgent Genetics RCV002483716 SCV002781800 uncertain significance Holt-Oram syndrome 2021-10-09 criteria provided, single submitter clinical testing
Baylor Genetics RCV002483716 SCV003835496 uncertain significance Holt-Oram syndrome 2022-09-10 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV003647793 SCV004536556 uncertain significance Aortic valve disease 2 2023-08-30 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBX5 protein function. ClinVar contains an entry for this variant (Variation ID: 519312). This variant has not been reported in the literature in individuals affected with TBX5-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 13 of the TBX5 protein (p.Thr13Lys).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.